Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 10-Q, filed Jul 30, 2026
- Filings on record
- 662 filings
- On EDGAR
- CIK 1253689
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 52
News 8 of 112
Prospectuses and Registrations 8 of 53
- POS AM Post-effective amendment to a registration Jul 30, 2026
- 424B3 Prospectus supplement for an offering Jul 30, 2026
- 424B5 Prospectus supplement for an offering Jul 15, 2026
- 424B5 Prospectus supplement for an offering Jul 14, 2026
- S-3 Shelf registration statement Jul 1, 2026
- 424B3 Prospectus supplement for an offering Jun 22, 2026
- 424B3 Prospectus supplement for an offering Apr 29, 2026
- 424B3 Prospectus supplement for an offering Mar 17, 2026
Proxies 8 of 18
- DEFA14A Extra proxy material Apr 21, 2026
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Jan 13, 2025
- DEFA14A Extra proxy material Nov 7, 2024
- DEFA14A Extra proxy material Oct 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2024
- PRE 14A Preliminary proxy statement Mar 22, 2024
Ownership 8 of 367
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 20, 2026
- 4 Insider reported a trade Jul 20, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
Other 8 of 60
- EFFECT Notice that a registration became effective Jul 31, 2026
- EFFECT Notice that a registration became effective Jul 10, 2026
- EFFECT Notice that a registration became effective Mar 3, 2026
- EFFECT Notice that a registration became effective Jan 15, 2026
- CORRESP Reply to SEC staff Jan 13, 2026
- UPLOAD Comment letter from SEC staff Jan 12, 2026
- S-4 POS Dec 12, 2025
- 8-A12B/A Registration of a security for exchange listing, amended Nov 6, 2025
Everything here comes from Crescent Biopharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.